Tagged with BIA

Colombia The latest news from the Colombian pharma market, including a new (legal) US cannabis deal; Bayer’s updated regional strategy; a pandemic-induced OTC product boom; Faes Farma’s growth; and why prostate cancer remains a significant concern in the country.   Colombia-Based Clever Leaves To Donate $25 Million Worth Of Cannabis To…

Saudi Arabia Dr Fayad Al Dandashi, CEO of Tamer HealthCare, a leading Saudi healthcare company, discusses how the group aims to benefit from Saudi Arabia’s healthcare transformation through digitalization, changing their product-oriented business model to a holistic service-driven business model. After years of entrepreneurial and public sector experience, he explains the changes…

Saudi Arabia Hussein El Hakim, managing director for Bayer Saudi Arabia and general manager for its pharmaceuticals division in the country, discusses the affiliate’s rapid expansion after years of double-digit growth. El Hakim explains how the German Life Science company is approaching the transformation of the Saudi healthcare market, with changes in…

Saudi Arabia As part of Saudi Arabia’s ambitious ‘Vision 2030’ economic transformation plan, the country has centralised the public procurement of medications through the National Unified Procurement Company for Medical Supplies (NUPCO). Here, some of the Kingdom’s most prominent pharma leaders weigh in on the impact of this new system for their…

Saudi Arabia Aymen Tamer, chairman and managing partner of historic Saudi healthcare firm Tamer Group, outlines how, informed by Saudi’s Vision 2030, the company is adapting to better meet the needs of the rapidly evolving domestic pharma market. Tamer also touches on the challenges of succession planning, why a deep and long-term…

Saudi Arabia Mohamed Fawzy highlights how Pfizer’s work in Saudi Arabia dovetails with the country’s ambitious ‘Vision 2030’ transformation strategy, the Saudi market’s increasing relevance to the company, and how Pfizer is working for the benefit of the Saudi people on COVID-19 vaccine access and beyond.   In simple terms, Vision 2030…

Saudi Arabia Ashraf Daoud, General Manager for AbbVie in Saudi Arabia, highlights how the affiliate has harnessed Allergan’s portfolio to become a top five company in the market with the objective of becoming the biopharma leader by 2022. In addition, Daoud discusses the impact that an internal Saudization strategy has had, the…

Saudi Arabia Lilly Saudi Arabia’s Dimitri Livadas shares some of the misconceptions he had before moving to the Kingdom a couple of years ago, highlights the evolution of the Saudi healthcare system with its current focus on digital health, the big opportunities for the Indiana-based company’s diabetes portfolio at a moment when…

Saudi Arabia 33-year pharma industry veteran Georg Schroeckenfuchs currently heads up the vast Middle East & Africa (MEA) region for Swiss behemoth Novartis, overseeing 19 countries, over 1800 employees, and more than USD 900 million in revenues. In a recent conversation within the frame of PharmaBoardroom’s current focus on Saudi Arabia, the…

Saudi Arabia Amgen’s Middle East and Africa General Manager Mohamed Nasser discusses the company’s approach to the region; the opportunities in the Saudi market, given its improved regulatory environment; and the disadvantages of its reference pricing system. In addition, Nasser explains Amgen’s approach to Saudization and the company’s place within Saudi Arabia’s…

Saudi Arabia Georg Schroeckenfuchs, Novartis’ president MEA and head of its Gulf and Saudi Country Group, explains how the company’s objectives are aligned with Saudi Arabia’s Vision 2030, the progress made towards the nationalization of its Saudi workforce, the potential impact of changes in the tender process, and why Novartis is uniquely…

Saudi Arabia Bristol Myers Squibb’s General Manager for the Middle East and Africa (MEA) Oscar Delgado outlines the company’s pandemic journey, the big changes transforming the Saudi market, the challenges on regulatory data protection, and the opportunities to make Saudi Arabia a leader in clinical trials and innovation within the region.  …